UPDATE 1-Pfizer wins first U.S. trial over Zoloft birth-defect risk

April 17 (Reuters) - Pfizer Inc was cleared of liability on Friday in the first lawsuit to go to trial of more than 1,000 filed across the United States alleging that its antidepressant Zoloft can cause birth defects, a company spokeswoman said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.